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Introduction 
Abnormalities in the serotonin system have been proposed to contribute to the pathophysiology of 
major depressive disorder (MDD). An interesting pathway would be the role of a dysregulated 
hypothalamic-pituitary-adrenal (HPA) axis, seen in patients suffering from MDD, in the disturbed 
serotonergic neurotransmission. The present study aimed to further explore this hypothesis, using the 
corticosterone (CORT) rodent depression model, combined with PET imaging. To our knowledge, this 
is the first preclinical study using PET to evaluate the effects of chronic CORT on the serotonin system.   
Methods 
The CORT depression model was induced by means of three weeks of chronic CORT administration (40 
mg/kg, s.c.) to male Long-Evans rats. Next to examining the CORT-induced effects on the behavioral 
level, the total body weight, the plasma corticosterone levels, and non-invasive imaging was done 
using three highly selective PET-radiotracers. These included [18F]MPPF, [18F]altanserin and [11C]DASB, 
which allowed the visualization of the serotonin 5-HT1A receptor, the 5-HT2A receptor, and the 
serotonin transporter, respectively. 
Results 
The chronic CORT administration resulted in significantly lowered body weight, significantly elevated 
plasma corticosterone levels, and induced depression-like behavior. Compared to the control group, 
induction of the CORT depression model resulted in significantly decreased BPND of [18F]MPPF on the 
5HT1A receptors in the medial prefrontal cortex and anterior cingulate cortex (ACC). At the 5-HT2A 
receptor level, the [18F]altanserin BPND was significantly increased in all cortical regions except for the 
ACC. No significant differences in regional BPND of [11C]DASB were detected. Overall, our findings at 
the 5HT1A and 5-HT2A receptor level are in line with previous ex vivo studies in rats. Furthermore, a 
diminished density of the 5-HT1A receptors and an elevated 5HT2A receptors has also been repeatedly 
observed in patients suffering from MDD. 
 Conclusion 
The present study emphasizes the potential role of a dysregulated HPA-axis in the disturbed 
serotonergic neurotransmission at the 5HT1A and 5HT2A receptor level, seen in patient with MDD. 
Furthermore, these results indicate the relevance and reliability of the corticosterone depression 
model in the investigation of the mode of action for current and novel antidepressant therapies on the 
serotonin 5-HT1A and 5-HT2A receptors in the brain.   
 
Effect of the CORT (n=6) and control (n=6) protocol on the regional [18F]MPPF BPND values. Compared to the control group, 
induction of the CORT model resulted in significantly reduced (* = p < 0.05) BPND values in the ACC and the MPFC. 
ACC=anterior cingulate cortex; Am=amygdala; Hip=hippocampus; and MPFC=medial prefrontal cortex.  
 











Fig 8: Effect of the CORT (n=6) and control (n=6) protocol on the regional [18F]altanserin BPND values.  Compared to the control 
group, induction of the CORT model resulted in significantly increased  (* = p < 0.05) BPND values in the EC, IC, MC, MPFC 
and OC. ACC=anterior cingulate cortex; Am=amygdala; EC=entorhinal cortex; IC=insular cortex; MC=motor cortex; 
MPFC=medial prefrontal cortex; OC=orbitofrontal cortex. 
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